VoxNeuro Inc., a commercial stage Software-as-a-Medical-Device (SaMD) brain health company that analyzes brain biomarkers to assess cognitive function, recently announced a new partnership with the Canadian Armed Forces (CAF). VoxNeuro and CAF have partnered to study the cognitive effects following intense military training regimens designed to reflect a combat environment and blast exposure. Despite the high prevalence of cognitive issues in veterans and active military personnel, there is relatively little understanding regarding these cognitive effects and reliable monitoring.
The study will assess the effects of repetitive, sub-concussive exposure (RSCE) on cognitive functioning and brain electrophysiology with CAF personnel undergoing cognitive testing in tandem with EEG recordings before and after military training. The study seeks to understand the relationship between RSCE and behavioural symptoms, vestibular dysfunction, neurophysiology, and cognition to aid in early detection, prevention, treatment, and prognosis.
VoxNeuro is an OBIO® member.